Duopharma Biotech BhdXKLS:7148 83 FCF Margin % is 7.31% as of Mar. 2026, which is 1524% above its 10-year median of 0.45. GuruFocus rates XKLS:7148 with a GF Score™ of 83/100 and a GF Value™ of RM1.52 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 958 Drug Manufacturers companies, Duopharma Biotech Bhd ranks better than 63.99% on this metric.
The historical rank and industry rank for Duopharma Biotech Bhd's FCF Margin % or its related term are showing as below:
XKLS:7148'
s FCF Margin % Range Over the Past 10 Years
Min: -11.23 Med: 0.45 Max: 7.91
Current: 7.39
During the past 13 years, the highest FCF Margin % of Duopharma Biotech Bhd was 7.91%. The lowest was -11.23%. And the median was 0.45%.
XKLS:7148's FCF Margin % is ranked better than 63.99% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.445
vs XKLS:7148: 7.39
Duopharma Biotech Bhd FCF Margin % Related Terms
Duopharma Biotech Bhd FCF Margin % Historical Data
* Premium members only.
The historical data trend for Duopharma Biotech Bhd's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7148 vs ZTS, UTHR, VTRS: FCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Duopharma Biotech Bhd's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Duopharma Biotech Bhd FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Duopharma Biotech Bhd's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Duopharma Biotech Bhd's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Duopharma Biotech Bhd (XKLS:7148) has a FCF Margin % of 7.31% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Duopharma Biotech Bhd and its competitors. This is 1524% above median its historical median of 0.45. According to the industry distribution chart, Duopharma Biotech Bhd ranks #345 out of 958 companies in the Drug Manufacturers industry, placing it in the top 36%.
Is Duopharma Biotech Bhd's FCF Margin % too high?
Duopharma Biotech Bhd's current FCF Margin % of 7.31% is 1524% above median its 10-year median of 0.45. The Drug Manufacturers industry median FCF Margin % is 2.45. Duopharma Biotech Bhd's value of 7.31% is 199% above this industry median. Based on the distribution chart, Duopharma Biotech Bhd ranks #345 out of 958 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Duopharma Biotech Bhd has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Duopharma Biotech Bhd's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Duopharma Biotech Bhd ranks #345 out of 958 companies for FCF Margin %. This puts Duopharma Biotech Bhd in the upper half of its industry. The industry median FCF Margin % is 2.45. Duopharma Biotech Bhd's value of 7.31% is 199% above this benchmark. While the company's 10-year median is 0.45 vs. the industry median of 2.45, Duopharma Biotech Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Duopharma Biotech Bhd's current FCF Margin % of 7.31% is 199% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Duopharma Biotech Bhd and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Duopharma Biotech Bhd's current FCF Margin % is 7.31%, which is 1524% above median its own 10-year median of 0.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Duopharma Biotech Bhd stock overvalued right now?
Based on GuruFocus' analysis, Duopharma Biotech Bhd (XKLS:7148) is currently considered Modestly Undervalued. The stock's GF Value™ is RM1.52, compared to a current price of RM1.20 — trading 21.1% below its estimated fair value. The current FCF Margin % is 7.31%, which is 1524% above median its 10-year median of 0.45 and 199% above the Drug Manufacturers industry median of 2.45. Duopharma Biotech Bhd's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Duopharma Biotech Bhd (XKLS:7148), the current FCF Margin % is 7.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Duopharma Biotech Bhd (XKLS:7148) Overvalued in 2026?
Based on GuruFocus' analysis, Duopharma Biotech Bhd stock appears to be undervalued.
The current stock price of RM1.20 is trading 21.1% below its estimated GF Value™ of RM1.52.
GuruFocus considers Duopharma Biotech Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:7148:
FCF Margin %: 7.31% (1524% above median its 10-year median of 0.45)
GF Value™: RM1.52 vs. price of RM1.20 (21.1% below fair value)
Industry Position: 199% above the Drug Manufacturers median (#345 of 958)
No single metric tells the full story. See the XKLS:7148 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. The company develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer, and exporter of pharmaceutical products and medicines. Geographically, the company generates the majority of its revenue from Malaysia.
83GF Score
Get the complete analysis for XKLS:7148
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7148 has been successfully added to your 
